In this study, we demonstrated that preoperative serum PGRN levels in HR-positive breast cancer patients were associated with recurrence (p for trend <0.05), even after adjustment for possible mediating factors, including clinical, tumor and treatment variables. The gene discussed is GRN; the disease is neoplasm.